Proactive Investors interview with Chairman Tim McCarthy – May 2019

ImmuPharma PLC’s (LON:IMM) chairman Tim McCarthy tells Proactive London’s Andrew Scott discussions with potential partners are ongoing as they consider the best route forward for its lead drug Lupuzor™